Blue Zones Under the Microscope β Does the Science Actually Hold Up
Eric Topol and colleagues question whether blue zone longevity data is real or a statistical mirage worth rethinking.
2910 articles in this topic
Eric Topol and colleagues question whether blue zone longevity data is real or a statistical mirage worth rethinking.
Hidden root infections trigger chronic inflammation that disrupts insulin function β and treating them may improve metabolic health.
AI4L uses 'Audit-Driven Prompting' to generate hallucination-free, evidence-based reviews of longevity therapies like senolytics and NAD+ boosters.
A comprehensive 2025 review maps the molecular and cellular mechanisms driving immune aging, from SASP to epigenetic drift.
Pre-existing immune aging signatures β not just chronological age β predict who progresses to severe COVID-19, new research shows.
SGLT2 inhibitor dapagliflozin protects diabetic kidneys by raising Ξ²-hydroxybutyrate and suppressing iron-driven cell death (ferroptosis).
A newly uncovered TRIM28-PARP1 axis depletes NAD+ in tumors and T cells, enabling immune evasion in clear cell renal cell carcinoma.
A new study shows targeting CD38 in melanoma restores T cell energy metabolism and overcomes resistance to immune checkpoint therapies.
Researchers reveal how mechanical confinement deforms the cell nucleus, fractures mitochondria, and ignites iron-driven cell deathβwith implications for osteoarthritis.
A comprehensive review reveals how iron homeostasis governs brain health from infancy through old age and drives Alzheimer's and Parkinson's disease.
B cell lymphoma rapidly drives young T cells into a molecular and epigenetic aged state, while truly old T cells prove strangely resistant.
New review reveals how different cancer cell death pathwaysβfrom ferroptosis to pyroptosisβdetermine whether tumors fuel or suppress immune responses.